U.S. market Closed. Opens in 11 hours 28 minutes

NVRO | Nevro Corp. Stock Overview

(Stock Exchange: NYSE)
Day's Range 5.84 - 5.85
52 Week Range 3.17 - 14.43
Beta 0.88
Implied Volatility 86.48%
IV Rank 1.99%
Day's Volume 238,299
Average Volume 1,236,735
Shares Outstanding 38,372,000
Market Cap 224,092,480
Sector Healthcare
Industry Medical - Devices
IPO Date 2014-11-06
Valuation
Profitability
Growth
Health
P/E Ratio -1.91
Forward P/E Ratio N/A
EPS -3.06
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 1,215
Country USA
Website NVRO
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
*Chart delayed
Analyzing fundamentals for NVRO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see NVRO Fundamentals page.

Watching at NVRO technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on NVRO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙